The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dang, Y.
Right arrow Articles by Heyborne, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dang, Y.
Right arrow Articles by Heyborne, K. D.
The Journal of Immunology, 2001, 166: 3641-3644.
Copyright © 2001 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Regulation of Uterine NKT Cells by a Fetal Class I Molecule Other Than CD11

Yushe Dang* and Kent D. Heyborne2,*,{dagger}

* Reproductive Immunology Laboratory, Swedish Medical Center, Denver CO 80110; and {dagger} Obstetrix Medical Group of Colorado, P.C. Denver, CO 80110

The peri-implantation uterus contains an expanded population of NK1.1+ V{alpha}14+ TCRint (NKT) lymphocytes. Although these cells bear the above features in common with other NKT cells populations in thymus, bone marrow, liver, and spleen, they differ from these other populations in terms of an altered V{beta} repertoire and absence of a CD4+ component. In this study, we demonstrate that the uterine population also differs from other NKT cell populations because they recognize a class I/class I-like molecule other than CD1, whereas most previously described V{alpha}14+ NKT cells are CD1-restricted. Moreover, the class I/class I-like molecule leading to the uterine NKT cell expansion may be supplied by the fetus. These data demonstrate a novel mechanism whereby the fetus is capable of modulating the maternal immune system.




This article has been cited by other articles:


Home page
Hum ReprodHome page
S. Shimada, E. H. Kato, M. Morikawa, K. Iwabuchi, R. Nishida, R. Kishi, K. Onoe, H. Minakami, and H. Yamada
No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage
Hum. Reprod., April 1, 2004; 19(4): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. U. Saikh, B. Dyas, T. Kissner, and R. G. Ulrich
CD56+-T-Cell Responses to Bacterial Superantigens and Immune Recognition of Attenuated Vaccines
Clin. Vaccine Immunol., November 1, 2003; 10(6): 1065 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. R. Sherwood, C. Y. Lin, W. Tao, C. A. Hartmann, J. E. Dujon, A. J. French, and T. K. Varma
{beta}2 Microglobulin Knockout Mice Are Resistant to Lethal Intraabdominal Sepsis
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1641 - 1649.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
T. Michimata, H. Tsuda, M. Sakai, M. Fujimura, K. Nagata, M. Nakamura, and S. Saito
Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D2-mediated manner
Mol. Hum. Reprod., February 1, 2002; 8(2): 181 - 187.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.